HighTower Advisors
ARMP icon

HighTower Advisors’s Armata Pharmaceuticals ARMP Stock Holding History

HighTower Advisors’s Portfolio ARMP Stock Details ARMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-714
Closed -$10K – 2208
2018
Q3 		$10K Hold
714
– – ﹤0.01% 2200
2018
Q2 		$11K Hold
714
– – ﹤0.01% 2134
2018
Q1 		$11K Buy
+714
New +$12.7K ﹤0.01% 2080

Other funds holding ARMP

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SXL
Summit X LLC Chesterfield, Missouri $536M AUM 15.36% 1-Year Est. Return
PP
Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

HighTower Advisors's ARMP Position: Q4 2018 in Review

HighTower Advisors sold out of Armata Pharmaceuticals (ARMP) in Q4 2018, closing a stake of 714 shares — an estimated $10K sold.

HighTower Advisors first reported a position in ARMP in Q1 2018 and held it in 3 quarters. The position peaked at $11K in Q2 2018. 24 funds tracked by Wall St. Rank hold ARMP as of Q4 2018.

  • HighTower Advisors reported no remaining Armata Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
  • HighTower Advisors sold 714 Armata Pharmaceuticals shares in Q4 2018, an estimated $10K.
  • HighTower Advisors first reported a position in Armata Pharmaceuticals in Q1 2018 and held it in 3 quarters.
  • HighTower Advisors's Armata Pharmaceuticals position peaked at $11K in Q2 2018.
  • 24 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q4 2018.

Based on HighTower Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.